The media database brings together all published information on platforms and products, as well as financial and corporate news.
Join our mailing list.
01/29/2014
2014 Financial Calendar
01/13/2014
Adocia strengthens its diabetic foot ulcer patent portfolio
01/06/2014
Adocia launches phase IIa clinical trial for its ultra-fast acting formulation of analog insulin
12/09/2013
Adocia signs an exclusive license on a nanotechnology which improves the efficacy of anti-tumoral agents by targeting their action into tumors
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
11/13/2013
Adocia announces the initiation of a clinical trial on its combination of the long-acting insulin Glargine and a fast-acting insulin analog
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
10/24/2013
Adocia announces revenues of EUR 4.7 M for Q3 of 2013 (with no cash impact) and maintained available cash at Eur 22.7 M
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
10/19/2013
Gérard Soula : interview by Gérald Bouchon, radio Lyon 1ère
07/29/2013
Adocia reacquires exclusive development rights to ultra-fast acting insulin analog. Adocia and Lilly terminate collaboration
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
03/18/2013
Adocia announces its phase III development program for the treatment of diabetic foot ulcer. This program has been validated by scientific advice from the European Medicines Agency
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
01/07/2013
Adocia announces its financial calendar for 2013 as well as its participation to upcoming investor conferences
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
10/22/2012
Adocia is extending its intellectual property to new formulations of monoclonal antibodies
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
10/01/2012
EASD 2012 – 48th Annual Meeting of the European Association for the Study of Diabetes – 1-5 October 2012, Messe Süd, Berlin, Germany
09/12/2012
Bio India International Conference – 12-13 septembre 2012, Grand Hyatt, Mumbai, Inde
09/07/2012
DFSICON 2012 – 11th Annual Meeting of Diabetic Foot Society of India – 7-9 September 2012, Hyderabad, India
09/04/2012
SFAF meeting – Half year 2012 results. At 14:30, NYSE EURONEXT, room Auditorium – 3 rue Cambon – 75001 Paris
09/02/2012
WUWHS 2012 – 4th Congress of the World Union of Wound Healing Societies – 2-6 September 2012, Yokohama, Japon
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
06/13/2012
Adocia announces a strengthened intellectual property on its lead project for its chronic wounds treatment
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
05/30/2012
Additional contribution to Liquidity Agreement with Dexia Securities France (French only)
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
04/26/2012
ADOCIA maintains its dynamic growth: revenue of 1st quarter 2012
Join our mailing list. Subscribe